Metropolitan Life Insurance CO Aeglea Bio Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.5 - $8.42 $40,656 - $97,806	-11,616 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$6.03 - $7.95 $70,044 - $92,347	11,616 New	11,616 $92,000
Q3 2021 Mar 30, 2023	SELL	$6.03 - $7.95 $2,550 - $3,362	-423 Reduced 3.51%	11,616 $92,000
Q3 2021 Nov 15, 2021	BUY	$6.03 - $7.95 $70,044 - $92,347	11,616 New	11,616 $92,000
Q2 2021 Aug 16, 2021	SELL	$6.32 - $8.38 $75 - $100	-12 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$6.76 - $8.57 $81,383 - $103,174	12,039 New	12,039 $95.3 Million
Q1 2021 Mar 30, 2023	SELL	$6.76 - $8.57 $12,073 - $15,306	-1,786 Reduced 12.92%	12,039 $95,000
Q1 2021 May 14, 2021	SELL	$6.76 - $8.57 $93,375 - $118,377	-13,813 Reduced 99.91%	12 $95,000
Q4 2020 Jun 22, 2023	BUY	$7.02 - $9.83 $97,051 - $135,899	13,825 New	13,825 $108,000
Q3 2020 Jun 26, 2023	BUY	$6.51 - $9.33 $90,000 - $128,987	13,825 New	13,825 $98,000
Q3 2020 Mar 30, 2023	SELL	$6.51 - $9.33 $494 - $709	-76 Reduced 0.55%	13,825 $98,000
Q3 2020 Nov 13, 2020	SELL	$6.51 - $9.33 $494 - $709	-76 Reduced 0.55%	13,825 $98,000
Q2 2020 Jun 26, 2023	BUY	$4.01 - $11.04 $55,743 - $153,467	13,901 New	13,901 $128,000
Q2 2020 Mar 30, 2023	BUY	$4.01 - $11.04 $14,580 - $40,141	3,636 Added 35.42%	13,901 $128,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $55,743 - $153,467	13,901 New	13,901 $129,000
Q4 2019 Feb 14, 2020	SELL	$7.23 - $8.55 $74,215 - $87,765	-10,265 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$6.42 - $9.0 $65,901 - $92,385	10,265 New	10,265 $78,000
Q3 2019 Mar 30, 2023	BUY	$6.42 - $9.0 $65,901 - $92,385	10,265 New	10,265 $78,000
Q3 2019 Nov 14, 2019	BUY	$6.42 - $9.0 $65,901 - $92,385	10,265 New	10,265 $79,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account